13 December 2021 - Australia is poised to become the largest producer of mRNA vaccines outside the US and Europe under a $2 billion plus deal with global pharmaceutical giant Moderna to build a plant in Melbourne capable of producing 100 million respiratory vaccines a year, including future COVID-19 booster doses.
A three-way partnership between the federal government, the Victorian government and Moderna, to be announced on Tuesday, will position Australia as the region’s main respiratory vaccine producer for future potential pandemics and seasonal flu.